MARKET

HZNP

HZNP

Horizon Therapeutics Plc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

38.25
-0.15
-0.39%
Closed 19:16 01/21 EST
OPEN
38.46
PREV CLOSE
38.40
HIGH
38.85
LOW
37.73
VOLUME
2.11M
TURNOVER
--
52 WEEK HIGH
38.85
52 WEEK LOW
20.05
MARKET CAP
7.16B
P/E (TTM)
199.63
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HZNP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 11 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HZNP News

  • FDA Approves TEPEZZATM (teprotumumab-trbw) for the Treatment of Thyroid Eye Disease (TED)
  • Business Wire.16h ago
  • FDA approves Horizon's drug for thyroid eye disease
  • Reuters.16h ago
  • Are Investors Undervaluing Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) By 37%?
  • Simply Wall St..3d ago
  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.6d ago

More

Industry

Pharmaceuticals
-0.31%
Pharmaceuticals & Medical Research
-0.39%

Hot Stocks

Name
Price
%Change

About HZNP

Horizon Therapeutics plc, formerly Horizon Pharma plc, is a rare disease biopharmaceutical company. The Company is focused on researching, developing and commercializing medicines that address needs for people impacted by rare and rheumatic diseases. The Company markets approximately 10 medicines, of which 6 are for rare and rheumatic diseases. The Company's marketed medicines are ACTIMMUNE (interferon gamma-1b), BUPHENYL (sodium phenylbutyrate) Tablets and Powder, DUEXIS (ibuprofen/famotidine), KRYSTEXXA (pegloticase), PENNSAID (diclofenac sodium topical solution) 2% weight per weight (w/w), or PENNSAID 2%, PROCYSBI (cysteamine bitartrate) delayed-release capsules, QUINSAIR (aerosolized form of levofloxacin), RAVICTI (glycerol phenylbutyrate) Oral Liquid, RAYOS (prednisone) delayed-release tablets and VIMOVO (naproxen/esomeprazole magnesium).
More

Webull offers Horizon Therapeutics PLC (HZNP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.